Fusion of dynamic contrast-enhanced magnetic resonance mammography at 3.0T with X-ray mammograms: Pilot study evaluation using dedicated semi-automatic registration software

4D co-registration of X-ray and MR-mammograms: initial clinical results and potential incremental diagnostic value

PURPOSE

4D co-registration of X-ray- and MR-mammograms (XM and MM) is a new method of image fusion. The present study aims to evaluate its clinical feasibility, radiological accuracy, and potential clinical value.

METHODS

XM and MM of 25 patients were co-registered. Results were evaluated by a blinded reader.

RESULTS

Precision of the 4D co-registration was "very good" (mean-score [ms]=7), and lesions were "easier to delineate" (ms=5). In 88.8%, "relevant additional diagnostic information" was present, accounting for a more "confident diagnosis" in 76% (ms=5).

CONCLUSION

4D co-registration is feasible, accurate, and of potential clinical value.

[Future of mammography-based imaging]

Mammography is the central diagnostic method for clinical diagnostics of breast cancer and the breast cancer screening program. In the clinical routine complementary methods, such as ultrasound, tomosynthesis and optional magnetic resonance imaging (MRI) are already combined for the diagnostic procedure. Future developments will utilize investigative procedures either as a hybrid (combination of several different imaging modalities in one instrument) or as a fusion method (the technical fusion of two or more of these methods) to implement fusion imaging into diagnostic algorithms. For screening there are reasonable hypotheses to aim for studies that individualize the diagnostic process within the screening procedure. Individual breast cancer risk prediction and individualized knowledge about sensitivity and specificity for certain diagnostic methods could be tested. The clinical implementation of these algorithms is not yet in sight.